Inventor · disambiguated record
Bingcan Liu
Also filed as: LIU BINGCAN
11 granted patents·15 pending applications·19 citations·filing 2004–2023
84Inventor score
Top patents by PatentIndex Score
26 records- 0186US8354419B2Benzimidazole analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2010·Granted Jan 15, 2013·10 cites·23 claims
- 0281US8779156B2Analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2012·Granted Jul 15, 2014·7 cites·27 claims
- 0373US11634447B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2020·Granted Apr 25, 2023·0 cites·20 claims
- 0471US9598454B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Granted Mar 21, 2017·1 cites·17 claims
- 0569US10669298B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2018·Granted Jun 2, 2020·0 cites·20 claims
- 0667US10913761B22,7-dibromospiro[fluorene-9,4′-piperidine] compoundsVERTEX PHARMA·Filed 2020·Granted Feb 9, 2021·0 cites·12 claims
- 0765US9890176B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2014·Granted Feb 13, 2018·1 cites·22 claims
- 0857US2014243257A1Benzimidazole analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2014·Application pending·0 cites
- 0956US9963478B2Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2016·Granted May 8, 2018·0 cites·32 claims
- 1054US2025304537A1Heteroarenes, pharmaceutical compositions containing the same, and methods of using the sameREPARE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1152US12435090B2Compounds, pharmaceutical compositions, and methods of preparing compounds and of their useREPARE THERAPEUTICS INC·Filed 2022·Granted Oct 7, 2025·0 cites·10 claims
- 1251US2023348456A1Quinazolinones, pharmaceutical compositions containing the same, and methods of using the sameREPARE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1351US2025177396A1Polo-like kinase 4 (plk4) inhibitors, pharmaceutical compositions, methods of preparation and uses thereofREPARE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1450US2025026748A1N-(5-substituted-[(1,3,4-thiadiazolyl) or (thiazolyl)])(substituted)carboxamide compounds and use thereof for inhibiting human polymerase thetaREPARE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1547US8269026B2Lupane derivatives useful for treating HIVMOINET CHRISTOPHE·Filed 2010·Granted Sep 18, 2012·0 cites·20 claims
- 1646US2019119282A1Imidazopyridazines useful as inhibitors of the par-2 signaling pathwayVERTEX PHARMA·Filed 2018·Application pending·0 cites
- 1744US2023158022A1Methods of using myt1 inhibitorsREPARE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1844US2014107049A1Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1943US2023151014A1Compounds, pharmaceutical compositions, and methods of preparing compounds and of their useREPARE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2043US2013102629A1Analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2141US10030024B2Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathwayVERTEX PHARMA·Filed 2016·Granted Jul 24, 2018·0 cites·23 claims
- 2241US2005176767A1Pyridine carboxamide and methods for inhibiting HIV integraseFiled 2004·Application pending·0 cites
- 2341US2013261077A1Mannose derivatives for treating bacterial infectionsVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2440US2013090364A1Analogues for the treatment or prevention of flavivirus infectionsVERTEX PHARMA·Filed 2012·Application pending·0 cites
- 2537US2013072523A1Analogues for the treatment or prevention of flavivirus infectionsLIU BINGCAN·Filed 2010·Application pending·0 cites
- 2630US2011077251A1Novel 17 beta lupane derivativesMOINET CHRISTOPHE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bingcan Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →